Price to Earning ratio Analysis of aTyr Pharma Inc - Deep Dive
Latest FY PE
Period Ending - Dec-23
Very Poor PE
-0.0248
Period Ending - Dec-22
Very Poor PE
-1.25
Growth
98.02 %
Trailing Twelve Months PE
Period Ending - Dec-23
Very Poor PE
-512.96
PE Analysis of aTyr Pharma Inc
P/E Ratio -512.96 of aTyr Pharma Inc is negative because of negative EPS. |
PE Ratio of LIFE rose handsomely by 98.02 % this year. |
PE Ratio with value of -0.0248 was highest in Year Dec-23 in last Five Years. |
PE Ratio with value of -1.25 was lowest in Year Dec-22 in last Five Years. |
Latest PE Ratio with value of -0.0248 is Greater than Average PE of -0.764 in last five years. |
Other PE Related Info of LIFE that may interest you.
aTyr Pharma Inc Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
LIFE | 2.0 | 1.93 | 3.63 % | Biotechnology |
Defination of Price to Earning
PE Ratio measures the relationship between the company's current stock price and EPS (Earnings Per Share). PE Ratio indicates how many times investors pay money to get 1 rupee of return. It is one of the important parameters to evaluate whether a company's stock price is overvalued or undervalued. more ..PE Related Ratios
PriceToSalesRatio | PriceToBookRatio | PriceToCashFlowRatio |
Tsr Value Index
Poor Value Stock |
FY - Historical Price to Earning of aTyr Pharma Inc
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
---|---|---|---|---|---|---|---|
PE | -0.0248 | -1.25 | -1.13 | -1.13 | -0.284 | -0.0089 | -0.0055 |
Change | 98.02 % | -10.93 % | -0.079 % | -297.14 % | -3110.44 % | -62.18 % | -30.75 % |
FY Chart of Price to Earning of aTyr Pharma Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)